Taxanes in cancer treatment: Activity, chemoresistance and its overcoming

L Mosca, A Ilari, F Fazi, YG Assaraf, G Colotti - Drug Resistance Updates, 2021 - Elsevier
Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced
ovarian carcinoma, taxanes have been widely used as microtubule-targeting antitumor …
被引用次数：182 相关文章

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming.

L Mosca, A Ilari, F Fazi, YG Assaraf… - Drug Resistance Updates …, 2021 - europepmc.org
Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced
ovarian carcinoma, taxanes have been widely used as microtubule-targeting antitumor …

Taxanes in cancer treatment: activity, chemoresistance and its overcoming

L Mosca, A Ilari, F Fazi, YG Assaraf… - DRUG RESISTANCE …, 2021 - iris.uniroma1.it
Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced
ovarian carcinoma, taxanes have been widely used as microtubule-targeting antitumor …

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming

L Mosca, A Ilari, F Fazi… - … updates: reviews and …, 2021 - pubmed.ncbi.nlm.nih.gov
Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced
ovarian carcinoma, taxanes have been widely used as microtubule-targeting antitumor …